|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn890470988 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140912s2014 ts o 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d BENTH
|d OCLCQ
|d EBLCP
|d OCLCF
|d OCLCQ
|d LVT
|d LDL
|d OCLCQ
|d VTS
|d AU@
|d STF
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 992839876
|
020 |
|
|
|a 9781608059140
|q (electronic bk.)
|
020 |
|
|
|a 1608059146
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000062570179
|
029 |
1 |
|
|a AU@
|b 000068483094
|
029 |
1 |
|
|a DEBBG
|b BV042793240
|
029 |
1 |
|
|a DEBBG
|b BV043032347
|
029 |
1 |
|
|a DEBSZ
|b 429955286
|
035 |
|
|
|a (OCoLC)890470988
|z (OCoLC)992839876
|
050 |
|
4 |
|a RM332.3
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.398
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Anti-obesity drug discovery and development .
|n Volume 2 /
|c editors, Atta-ur-Rahman, M. Iqbal Choudhary.
|
264 |
|
1 |
|a [Sharjah, United Arab Emirates] :
|b Bentham Books,
|c [2014]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Cover; Title; EUL; Contents; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Index.
|
520 |
|
|
|a Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs. Anti-obesity Drug Discovery and Development is focused on this very imp.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Appetite depressants.
|
650 |
|
0 |
|a Obesity.
|
650 |
|
2 |
|a Appetite Depressants
|
650 |
|
2 |
|a Obesity
|
650 |
|
6 |
|a Anorexigènes.
|
650 |
|
6 |
|a Obésité.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Appetite depressants
|2 fast
|
650 |
|
7 |
|a Obesity
|2 fast
|
700 |
1 |
|
|a Rahman, Atta-ur-
|
700 |
1 |
|
|a Choudhary, M. Iqbal.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=839184
|z Texto completo
|
938 |
|
|
|a Bentham Science Publisher
|b BENT
|n 9781608059140
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1777732
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 839184
|
994 |
|
|
|a 92
|b IZTAP
|